|
US3658849A
(en)
|
1969-02-19 |
1972-04-25 |
Reynolds Tobacco Co R |
Treatment of 2-substituted aldehydes with lead dioxide
|
|
DE3045373A1
(de)
|
1980-12-02 |
1982-07-01 |
Henkel KGaA, 4000 Düsseldorf |
Verwendung von estern der 3-hydrody-2,2-dimethylpropionsaeure als riechstoffe, diese enthaltende riechstoffkompositionen und 3-hydroxy-2,2-dimethyl-propionsaeurepropylester
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
TR200003199T2
(tr)
*
|
1998-05-01 |
2001-03-21 |
Kyoto Pharmaceutical Industries, Ltd. |
Karbapenem türevleri, bunların kullanımı ve ara birleşiği
|
|
FR2812635B1
(fr)
|
2000-08-01 |
2002-10-11 |
Aventis Pharma Sa |
Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
|
|
WO2002092606A1
(en)
|
2001-05-15 |
2002-11-21 |
Takeda Chemical Industries, Ltd. |
Fused imidazolidine derivatives, process for preparation of the same and use thereof
|
|
WO2009151392A1
(en)
|
2008-06-14 |
2009-12-17 |
Astrazeneca Ab |
Novel derivatives of 11-piperazin-l-yldibenzo [b,f] [1,4] thiazepine for treating at least one syndrome or condition associated with schizophrenia and other psychotic disorders
|
|
TW200808731A
(en)
|
2006-03-30 |
2008-02-16 |
Tanabe Seiyaku Co |
A process for preparing tetrahydroquinoline derivatives
|
|
US20090082464A1
(en)
|
2007-09-07 |
2009-03-26 |
Bernd Jandeleit |
Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
|
|
EP2217564A1
(en)
|
2007-09-07 |
2010-08-18 |
XenoPort, Inc. |
Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
|
|
US20090099253A1
(en)
|
2007-10-15 |
2009-04-16 |
Xenoport, Inc. |
Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use
|
|
WO2009091856A2
(en)
|
2008-01-18 |
2009-07-23 |
Merck & Co., Inc. |
Beta-lactamase inhibitors
|
|
GB0801401D0
(en)
|
2008-01-25 |
2008-03-05 |
Barry Callebaut Ag |
Composition
|
|
WO2009100045A1
(en)
|
2008-02-04 |
2009-08-13 |
Translational Genomics Research Institute |
Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
|
|
WO2010032147A2
(en)
|
2008-09-19 |
2010-03-25 |
Pfizer Inc. |
Hydroxamic acid derivatives useful as antibacterial agents
|
|
WO2010065709A2
(en)
|
2008-12-03 |
2010-06-10 |
Amin Khan |
Hydroxamic acid derivatives, preparation and therapeutic uses thereof
|
|
US20120053350A1
(en)
*
|
2009-04-30 |
2012-03-01 |
Ian Mangion |
Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
|
|
US8859776B2
(en)
|
2009-10-14 |
2014-10-14 |
Merck Sharp & Dohme Corp. |
Substituted piperidines that increase p53 activity and the uses thereof
|
|
CA2796750C
(en)
|
2010-04-20 |
2017-09-19 |
Taisho Pharmaceutical Co., Ltd. |
Novel hydroxamic acid derivative
|
|
WO2011150380A1
(en)
|
2010-05-28 |
2011-12-01 |
Xenoport, Inc. |
Methods of treatment of fragile x syndrome, down's syndrome, autism and related disorders
|
|
US8772490B2
(en)
|
2010-12-22 |
2014-07-08 |
Meiji Seika Pharma Co., Ltd. |
Optically active diazabicyclooctane derivatives and process for preparing the same
|
|
PL2657234T3
(pl)
|
2010-12-22 |
2017-06-30 |
Meiji Seika Pharma Co., Ltd. |
Optycznie czynna pochodna diazabicyklooktanowa i sposób jej wytwarzania
|
|
HUE027447T2
(en)
|
2011-05-30 |
2016-09-28 |
Sumitomo Chemical Co |
Cyclohexanone compounds and herbicides containing them
|
|
US8796257B2
(en)
|
2011-12-02 |
2014-08-05 |
Naeja Pharmaceutical Inc. |
Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
|
|
BR112017004796A2
(pt)
|
2014-09-12 |
2017-12-12 |
Toyama Chemical Co Ltd |
método para utilizar derivados de ácido hidroxâmico e substância antibacterial em combinação
|
|
RU2017112319A
(ru)
|
2014-09-12 |
2018-10-12 |
Тояма Кемикал Ко., Лтд. |
Новая фармацевтическая композиция, содержащая производное гидроксамовой кислоты или его соль
|
|
WO2016116788A1
(en)
|
2015-01-24 |
2016-07-28 |
Wockhardt Limited |
Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
|
|
EP3281942A4
(en)
|
2015-09-16 |
2018-08-15 |
Xuanzhu Pharma Co., Ltd. |
B-lactamase inhibitor and application thereof
|
|
US20170165371A1
(en)
|
2017-02-22 |
2017-06-15 |
Joel Steven Goldberg |
Novel synthesis of potential ester prodrugs
|
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
|
EP3676247B8
(en)
|
2017-10-02 |
2023-04-12 |
Arixa Pharmaceuticals, Inc. |
Aztreonam derivatives and uses thereof
|